Neurological Disorders Identified during Treatment of a SARS-CoV-2 Infection

Internal Medicine - Tập 59 Số 17 - Trang 2187-2189 - 2020
Shinichi Wada1, Yoji Nagasaki2, Yoko Arimizu2, Masatoshi Shimo3, Yuta Matsukuma4, Masaki Okamoto5, Shinichirou Yoshida6, Ikkei Ohashi1, Go Hashimoto1, Takahiro Kuwashiro1, Masahiro Yasaka1, Yasushi Okada1
1Division of Cerebrovascular Medicine and Neurology, Clinical Research Institute, National Hospitalization Organization, Kyushu Medical Center, Japan
2Division of Infectious Diseases, Clinical Research Institute, National Hospitalization Organization, Kyushu Medical Center, Japan
3Division of Hematology, Clinical Research Institute, National Hospitalization Organization, Kyushu Medical Center, Japan
4Department of Nephrology, National Hospitalization Organization, Kyushu Medical Center, Japan
5Department of Respiratory Medicine, Clinical Research Institute, National Hospitalization Organization, Kyushu Medical Center, Japan
6Department of Emergency and Critical Care Medicine, Clinical Research Institute, National Hospitalization Organization, Kyushu Medical Center, Japan

Tóm tắt

Từ khóa


Tài liệu tham khảo

1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan China. Lancet 395: 497-506, 2020.

2. Yang X, Yu Y, Xu J, et al. Clinical course and outcome of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 8: 475-481, 2020.

3. Yousefifard M, Zali A, Mohamed Ali K, et al. Antiviral therapy in management of COVID-19: a systematic review on current evidence. Arch Acad Emerg Med 8: e45, 2020.

4. Wang Z, Chen X, Lu Y, Chen F, Zhang W. Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. Biosci Trends 14: 64-68, 2020.

5. Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol 19: 383-384, 2020.

6. Moriguchi T, Harii N, Goto J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis 94: 55-58, 2020.

7. Needham EJ, Chou SH, Coles AJ, Menon DK. Neurological implications of COVID-19 infections. Neurocrit Care 32: 667-671, 2020.

8. Leonhard SE, Mandarakas MR, Gondim FAA, et al. Diagnosis and management of Guillain-Barré syndrome in ten steps. Nat Rev Neurol 15: 671-683, 2019.

9. Zhou C, Wu L, Ni F, Ji W, Wu J, Zhang H. Critical illness polyneuropathy and myopathy: a systematic review. Neural Regen Res 9: 101-110, 2014.

10. Koike H, Watanabe H, Sobue G. The spectrum of immune-mediated autonomic neuropathies: insights from the clinicopathological features. J Neurol Neurosurg Psychiatry 84: 98-106, 2013.

11. Ishikura T, Takata K, Kinoshita M, Fukuda K, Sawada J, Hazama T. A case of acute autonomic and sensory neuropathy (AASN) with antibody against a mixture of galactocerebroside and phospholipids. Rinsho Shinkeigaku 57: 33-36, 2017 (in Japanese, Abstract in English).

12. Kusunoki S, Morita D, Ohminami S, Hitoshi S, Kanazawa I. Binding of immunoglobulin G antibodies in Guillain-Barré syndrome sera to mixture of GM1 and a phospholipid: possible clinical implications. Muscle Nerve 27: 302-306, 2003.

13. Mader I, Stock KW, Ettlin T, Probst A. Acute disseminated encephalomyelitis: MR and CT features. AJNR Am J Neuroradiol 17: 104-109, 1996.

14. Granerod J, Davies NWS, Mukonoweshuro W, et al. Neuroimaging in encephalitis: analysis of imaging findings and interobserver agreement. Clin Radiol 71: 1050-1058, 2016.

15. Toscano S, Palmerini F, Ravaglia S, et al. Guillain-Barré syndrome associated with SARS-CoV-2. N Engl J Med 382: 2574-2576, 2020.

16. Virani A, Rabold E, Hanson T, et al. Guillain-Barré syndrome associated with SARS-CoV-2 infection. IDCases. Forthcoming.

17. Sedaghat Z, Karimi N. Guillain-Barré syndrome associated with COVID-19 infection: a case report. J Clin Neurosci 76: 233-235, 2020.

18. Meyer Sauteur PM, Huizinga R, Tio-Gillen AP, et al. Intrathecal antibody responses to GalC in Guillain-Barré syndrome triggered by <i>Mycoplasma pneumoniae</i>. J Neuroimmunol 314: 13-16, 2018.

19. Kusunoki S, Shiba M, Kanazawa I. Anti-Gal-C antibodies in GBS subsequent to <i>Mycoplasma</i> infection: evidence of molecular mimicry. Neurology 57: 736-738, 2001.

20. Ang CW, Tio-Gillen AP, Groen J, et al. Cross-reactive anti-galactrocerebroside antibodies and <i>Mycoplasma pneumoniae</i> infections in Guillain-Barré syndrome. J Neuroimmunol 130: 179-183, 2002.

21. Capers KN, Turnacioglu S, Leshner RT, Crawford JR. Antiretroviral therapy-associated acute motor and sensory axonal neuropathy. Case Rep Neurol 3: 1-6, 2001.

22. Foster P, Cheung T, Craft P, et al. Novel approach to reduce transmission of COVID-19 during tracheostomy. J Am Coll Surg 230: 1102-1104, 2020.

23. Khamiees M, Raju P, DeGirolamo A, Amoateng-Adjepong Y, Manthous CA. Predictors of extubation outcome in patients who have successfully completed a spontaneous breathing trial. Chest 120: 1262-1270, 2001.

Thông tin
Thông tin xuất bản

Internal Medicine

Tập 59 Số 17

2187-2189

Thông tin tác giả